Concord Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.04M Sell
11,144
-509
-4% -$174K 0.46% 51
2026
Q1
$4.1M Buy
11,653
+1,818
+18% +$648K 0.53% 44
2025
Q4
$3.22M Buy
9,835
+135
+1% +$42.8K 0.42% 54
2025
Q3
$2.74M Buy
9,700
+233
+2% +$67.6K 0.38% 59
2025
Q2
$2.64M Sell
9,467
-448
-5% -$127K 0.39% 62
2025
Q1
$3.09M Buy
9,915
+911
+10% +$269K 0.51% 51
2024
Q4
$2.35M Buy
9,004
+480
+6% +$142K 0.38% 63
2024
Q3
$2.75M Buy
8,524
+341
+4% +$112K 0.46% 53
2024
Q2
$2.56M Buy
8,183
+270
+3% +$79.3K 0.45% 53
2024
Q1
$2.25M Buy
7,913
+1,172
+17% +$343K 0.4% 59
2023
Q4
$1.94M Buy
6,741
+1,809
+37% +$493K 0.39% 57
2023
Q3
$1.33M Buy
4,932
+14
+0.3% +$3.49K 0.28% 64
2023
Q2
$1.09M Buy
4,918
+1,510
+44% +$350K 0.24% 65
2023
Q1
$824K Sell
3,408
-312
-8% -$76.6K 0.23% 60
2022
Q4
$977K Sell
3,720
-327
-8% -$87.7K 0.29% 48
2022
Q3
$912K Buy
4,047
+86
+2% +$20.8K 0.29% 52
2022
Q2
$964K Buy
3,961
+325
+9% +$79.6K 0.26% 51
2022
Q1
$879K Buy
3,636
+458
+14% +$105K 0.23% 59
2021
Q4
$715K Buy
3,178
+1,917
+152% +$405K 0.18% 73
2021
Q3
$268K Sell
1,261
-923
-42% -$212K 0.11% 69
2021
Q2
$532K Buy
2,184
+237
+12% +$58.3K 0.15% 63
2021
Q1
$484K Buy
1,947
+922
+90% +$220K 0.16% 60
2020
Q4
$236K Buy
+1,025
New +$236K 0.18% 62

Other funds holding AMGN

Concord Wealth Partners's AMGN Position: Q2 2026 in Review

Concord Wealth Partners reduced its Amgen (AMGN) stake by 4.4% in Q2 2026, selling an estimated $174K and leaving 11,144 shares worth $4.04M. The position accounts for 0.46% of the portfolio, ranked #51.

Concord Wealth Partners first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.1M in Q1 2026. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Concord Wealth Partners held 11,144 shares of Amgen worth $4.04M as of Q2 2026.
  • Concord Wealth Partners sold 509 Amgen shares in Q2 2026, an estimated $174K.
  • Amgen made up 0.46% of Concord Wealth Partners's portfolio in Q2 2026, its #51 holding.
  • Concord Wealth Partners first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
  • Concord Wealth Partners's Amgen position peaked at $4.1M in Q1 2026.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.